Amylyx Pharmaceuticals Inc (AMLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 247,760 | 114,563 | 62,526 | 107,734 | 67,440 |
| Marketable Securities | 109,516 | 231,111 | 284,419 | 54,859 | 139,241 |
| Receivables | 33,473 | 17,555 | 15,306 | 137 | N/A |
| Inventories | 24,858 | 13,075 | 9,769 | 563 | N/A |
| Other current assets | 0 | 0 | 0 | 570 | 0 |
| TOTAL | $427,394 | $389,053 | $382,133 | $172,199 | $216,139 |
| Non-Current Assets | |||||
| PPE Net | 2,637 | 2,559 | 2,611 | 2,118 | 1,857 |
| Other Non-Current Assets | 23,557 | 16,346 | 6,709 | 7,126 | 7,244 |
| TOTAL | $26,194 | $18,905 | $9,320 | $9,244 | $9,101 |
| Total Assets | $453,588 | $407,958 | $391,453 | $181,443 | $225,240 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 24,695 | 10,770 | 6,257 | 7,052 | 8,117 |
| Accrued Expenses | 37,241 | 38,753 | 38,312 | 23,605 | 17,260 |
| TOTAL | $64,082 | $51,616 | $46,609 | $32,647 | $27,164 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,141 | 3,694 | 4,237 | 4,768 | 5,287 |
| TOTAL | $3,141 | $3,694 | $4,237 | $4,768 | $5,287 |
| Total Liabilities | $67,223 | $55,310 | $50,846 | $37,415 | $32,451 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 67,378 | 67,176 | 66,716 | 66,256 | 58,533 |
| Common Shares | 7 | 7 | 7 | 6 | 6 |
| Retained earnings | -330,573 | -352,647 | -354,220 | -311,516 | -257,760 |
| Other shareholders' equity | -72 | 25 | -86 | -725 | -196 |
| TOTAL | $386,365 | $352,648 | $340,607 | $144,028 | $192,789 |
| Total Liabilities And Equity | $453,588 | $407,958 | $391,453 | $181,443 | $225,240 |